United Therapeutics
UTHR
$229.91
Share price
2.61%
Change (1 day)
0.61%
Change (1 year)
Categories
P/S ratio for United Therapeutics (UTHR)
P/S ratio as of September 2023 (TTM): 5.11
According to United Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.11169. At the end of 2023 the company had a P/S ratio of 4.90.
P/S ratio history for United Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.90 | -25.14% |
| 2022 | 6.55 | 13.37% |
| 2021 | 5.77 | 26.96% |
| 2020 | 4.55 | 70.46% |
| 2019 | 2.67 | -8.51% |
| 2018 | 2.92 | -21.3% |
| 2017 | 3.71 | -2.62% |
| 2016 | 3.81 | -22.17% |
| 2015 | 4.89 | 3.28% |
| 2014 | 4.73 | -7.2% |
| 2013 | 5.10 | 74.38% |
| 2012 | 2.93 | -20.79% |
| 2011 | 3.69 | -38.71% |
| 2010 | 6.03 | -21.93% |
| 2009 | 7.72 | 49.54% |
| 2008 | 5.16 | -49.88% |
| 2007 | 10.3 | 40.8% |
| 2006 | 7.31 | -47.4% |
| 2005 | 13.9 | 1.05% |
| 2004 | 13.8 | 50.09% |
| 2003 | 9.17 | -20.97% |
| 2002 | 11.6 | -68.42% |
| 2001 | 36.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.35 | -54.09% | 🇺🇸 USA |
 Eli Lilly LLY | 17.7 | 246.06% | 🇺🇸 USA |
 Baxter BAX | 1.26 | -75.38% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.44 | -32.76% | 🇺🇸 USA |
 Cardinal Health CAH | 0.1084 | -97.88% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.18 | -57.41% | 🇬🇧 UK |
 Cytokinetics
CYTK | 289 | 5,561.20% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.7872 | -84.60% | 🇮🇱 Israel |